SUBOXONE
Identification of Suboxone
No description |
Google image searchProduct monograph
Active ingredients
buprenorphine (buprenorphine hydrochloride), 16 MG
naloxone (naloxone hydrochloride dihydrate), 4 MG
DIN: 02468093
Dosage form(s): TABLET
Route(s) of administration: SUBLINGUAL
Schedule: Narcotic (CDSA I)
Company: INDIVIOR UK LIMITED
Date: 14-FEB-2018
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07B — DRUGS USED IN ADDICTIVE DISORDERS (ATC, ATC/DDD)
- N07BC — Drugs used in opioid dependence (ATC, ATC/DDD)
- N07BC51 — BUPRENORPHINE, COMBINATIONS (ATC/DDD)
Reference brand drug: Suboxone